YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Gadolinium
NSF / NFD Associated with Gadolinium Based Contrast Agents More Common and Deadly than Previously Thought
Oct 17, 2007 | Parker Waichman Alonso LLP
Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy (NSF/NFD), a painful conditions that has been linked to the use of gadolinium based...
Gadolinium Based Contrast Agents Used in MRIs Get New FDA Black Box Warning
Sep 28, 2007 | Parker Waichman Alonso LLP
Today, the Food & Drug Administration (FDA) issued a “Dear Healthcare Professional” letter to inform practitioners of recent changes...
Nephrogenic Systemic Fibrosis Research Yields Few Clues Into Devastating Disease
Aug 24, 2007 | Parker Waichman Alonso, LLP
Since 1997, medical science has been trying to solve the mystery of Nephrogenic Systemic Fibrosis (NSF). NSF, also known as Nephrogenic...
Gadolinium Contrast Used in MRI / MRA Can Cause NSF & NFD
Aug 8, 2007 | Parker Waichman Alonso, LLP
Gadolinium contrast agents have long been used in Magnetic Resonance Imagining (MRI) to enhance the quality of images. But in some patients,...
Parker Waichman Alonso LLP, are Investigating Numerous Claims for Injuries Sustained as a Result of Gadolinium Based Contrast Agent Injections Used During MRI Scans
May 23, 2007 | Parker Waichman Alonso LLP
Parker Waichman Alonso LLP recently learned that the Federal Drug Administration (FDA) has notified healthcare professionals of the Agency’s...
Gadolinium MRI/MRA Contrast Dye
